🕒

RSS JSON

partially fodmap about corp required label company its food fsis modify nutrient that twitter order usda petition amendment circuit lawsuit privacy ninth claims aside fda according var content set approval plaintiff protections longer

2 Résultats (1 - 2)

🌍 FTC Seeks Comment on X Corp. Petition to Set Aside or Modify FTC Order Concerning Twitter (Federal Trade Commission - Protecting America's Consumers)

[4/6/2026] : The Federal Trade Commission is seeking public comment on a petition from X Corp., formerly known as Twitter, to set aside or modify its 2022 settlement order with the agency . In its petition to the Commission, X Corp. cited several reasons why it believes that the order should either be set aside or modified so that it terminates at the end of 2026. The petition argues: The order was imposed on a company that no longer exists, that every individual responsible for the underlying failures has left the company and that X Corp. has since built a world-class privacy and data-protection program; The order no longer serves any valid regulatory purpose, imposing millions of dollars in needless costs to address obligations and protections already required by domestic and international privacy regimes and industry-recognized frameworks that X Corp. follows; Setting aside the order safeguards First Amendment values; and Setting aside or modifying the order is critical to advancing American leadership in artificial i[...]

🌍 Ninth Circuit Partially Revives ‘Low-FODMAP’ Labeling Suit (The Daily Intake)

[5/8/2026] : A Ninth Circuit panel has partially revived (Law360 subscription required) a lawsuit alleging that FDA and USDA nutrient content claim regulations violate First Amendment rights by preventing the inclusion of certain information about fermentable oligosaccharides, disaccharides, monosaccharides, and poloyols (FODMAPs) on food labels. The lawsuit was initially filed against FDA, USDA, and USDA's Food Safety Inspection Service (FSIS) in March 2023 after one plaintiff submitted a label to FSIS for approval. FSIS denied the approval, telling the company that it must “remove all references to digestible, gut loving, and fodmap.” According to the plaintiff, FDA had never raised concerns about the claims on labels of FDA-regulated foods. According to the Ninth Circuit, FSIS told the company that it discussed the proposed label with FDA, and FDA agreed that the FODMAP claims were impermissible nutrient content claims. The company modified the label, then filed the lawsuit along with a consumer plaintiff. The plainti[...]